Search

Lisa M Monteggia

from Nashville, TN
Age ~57

Lisa Monteggia Phones & Addresses

  • 3723 Central Ave, Nashville, TN 37205
  • 4115 Willow Ridge Dr, Dallas, TX 75244 (972) 243-6361
  • 3001 Sale St, Dallas, TX 75219
  • 2808 Mckinney Ave, Dallas, TX 75204
  • West Haven, CT
  • Gurnee, IL
  • Lindenhurst, IL
  • Urbana, IL
  • Lindenhurst, IL

Work

Company: Vanderbilt university Sep 2018 Position: Director, vanderbilt brain institute

Skills

Research

Languages

English

Industries

Research

Resumes

Resumes

Lisa Monteggia Photo 1

Director, Vanderbilt Brain Institute

View page
Location:
4115 Willow Ridge Dr, Dallas, TX 75244
Industry:
Research
Work:
Vanderbilt University
Director, Vanderbilt Brain Institute

Ut Southwestern Medical Center at Dallas Jan 2003 - Sep 2009
Assistant Professor

Ut Southwestern Medical Center at Dallas Jan 2003 - Sep 2009
Associate Professor

Ut Southwestern Medical Center at Dallas Sep 2000 - Dec 2002
Research Assistant Professor

Yale University School of Medicine Jul 1998 - Aug 2000
Postdoctoral Fellow
Skills:
Research
Languages:
English

Publications

Us Patents

Variant Human 7 Acetylcholine Receptor Subunit, And Methods Of Production And Use Thereof

View page
US Patent:
6683157, Jan 27, 2004
Filed:
Sep 18, 2001
Appl. No.:
09/954936
Inventors:
Clark A. Briggs - Libertyville IL
Murali Gopalakrishnan - Grayslake IL
David G. Mc Kenna - McHenry IL
Lisa M. Monteggia - Lindenhurst IL
Jean-Marc Roch - Waukegan IL
James P. Sullivan - Deerfield IL
Edward Touma - North Chicago IL
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
C07K 14705
US Classification:
530350, 530402, 536 235
Abstract:
A variant human 7 nicotinic acetylcholine receptor (nAChR) polypeptide is provided wherein the variant contains an amino acid substitution at the valine-274 position of the wild-type human 7 nAChR. Nucleic acid molecules encoding the variant human 7 nAChR, vectors and host cells containing such nucleic acid molecules are also provided. In addition, methods are provided for producing the variant as are methods of using such variants for screening compounds for activity at the nAChR.

Variant Human Α7 Acetylcholine Receptor Subunit, And Methods Of Production And Use Thereof

View page
US Patent:
7229779, Jun 12, 2007
Filed:
Dec 30, 2003
Appl. No.:
10/749075
Inventors:
Clark A. Briggs - Libertyville IL, US
Murali Gopalakrishnan - Grayslake IL, US
David G. Mc Kenna - McHenry IL, US
Lisa M. Monteggia - Lindenhurst IL, US
Jean-Marc Roch - Waukegan IL, US
James P. Sullivan - Deerfield IL, US
Edward Touma - North Chicago IL, US
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
G01N 33/566
US Classification:
435 721, 436501
Abstract:
A variant human α7 nicotinic acetylcholine receptor (nAChR) polypeptide is provided wherein the variant contains an amino acid substitution at the valine-274 position of the wild-type human α7 nAChR. Nucleic acid molecules encoding the variant human α7 nAChR, vectors and host cells containing such nucleic acid molecules are also provided. In addition, methods are provided for producing the variant as are methods of using such variants for screening compounds for activity at the nAChR.

Variant Human .Alpha.7 Acetylcholine Receptor Subunit, And Methods Of Production And Uses Thereof

View page
US Patent:
63230003, Nov 27, 2001
Filed:
Dec 20, 1996
Appl. No.:
8/771737
Inventors:
Clark A. Briggs - Libertyville IL
Murali Gopalakrishnan - Grayslake IL
David G. McKenna - McHenry IL
Lisa M. Monteggia - Lindenhurst IL
Jean-Marc Roch - Waukegan IL
James P. Sullivan - Deerfield IL
Edward Touma - North Chicago IL
International Classification:
C12P 2102
C07H 2102
C07H 2104
C12N 1563
US Classification:
435 691
Abstract:
A variant human. alpha. 7 nicotinic acetylcholine receptor (nAChR) polypeptide is provided wherein the variant contains an amino acid substitution at the valine-274 position of the wild-type human. alpha. 7 nAChR. Nucleic acid molecules encoding the variant human. alpha. 7 nAChR, receptors and host cells containing such nucleic acid molecules are also provided. In addition, methods are provided for producing the variant as are methods of using such variants for screening compounds for activity at the nAChR.
Lisa M Monteggia from Nashville, TN, age ~57 Get Report